Metabolomics Creative Proteomics
Sample Submission Guidelines Inquiry
Request a Quote

Neurotransmitter Analysis Service — LC-MS/MS Quantification of 30+ Neurotransmitters & Metabolites Across 5 Pathways

Measuring neurotransmitters is not just about detecting dopamine or serotonin — it is about understanding synthesis, release, and metabolic clearance as a dynamic system. A single static concentration tells you little; the ratio of a metabolite to its parent neurotransmitter reveals whether neurons are firing more, reuptake is blocked, or enzymatic degradation is upregulated. Our targeted LC-MS/MS panel quantifies 30+ neurotransmitters and their metabolites across 5 pathways — catecholamines, serotonin, GABA/glutamate, acetylcholine, and histamine — with stable isotope internal standards. From brain tissue microdissection to CSF microdialysate to plasma with stabilizers, we deliver absolute concentrations (ng/mL or ng/g) plus pre-calculated turnover ratios, documented LOD, and full batch QC for every sample.

30+ analytes across 5 neurotransmitter pathways — catecholamine, serotonin, GABA/glutamate, acetylcholine, histamine — with pathway-specific metabolite ratios

Absolute quantification with stable isotope internal standards — 6-8 point calibration curves, 1/x2 weighted regression, R2 above or equal to 0.99

Validated for 5 brain-relevant matrices — brain tissue (fresh/frozen/microwave-fixed), CSF (5-50 uL), plasma with antioxidant stabilizers, urine, and microdialysate

Pre-calculated turnover & activity indices — HVA/DA, 5-HIAA/5-HT, MHPG/NE, Gln/Glu ratios provided with your data

Neurotransmitter Analysis Service — LC-MS/MS Targeted Quantification of 30+ Neurotransmitters Across 5 Pathways

Neurotransmitter Detection Panel — 30+ Analytes Organized by Pathway

Each analyte is quantified against its own stable isotope-labeled internal standard. The panel is organized by biosynthetic pathway because parent-to-metabolite ratios are the biologically informative readout — a single concentration number without pathway context reveals little about neuronal activity. Each pathway sub-page provides dedicated compound lists, sample requirements, and method details.

Catecholamine Pathway — Dopamine, Norepinephrine, Epinephrine & Metabolites

Analyte Role Key Ratio / Index Biological Significance
Dopamine (DA) Neurotransmitter HVA/DA (dopamine turnover) Rate-limiting step of reward, motor control, and cognition pathways. HVA/DA ratio is the gold-standard dopamine turnover index — elevated when dopaminergic neurons are firing more or MAO/COMT activity is upregulated.
3,4-Dihydroxyphenylacetic acid (DOPAC) Intraneuronal metabolite (MAO) DOPAC/DA Formed inside the presynaptic terminal by MAO before DA is released. DOPAC/DA reflects intraneuronal MAO activity — drops under MAO inhibition, rises with increased DA synthesis.
Homovanillic acid (HVA) Terminal metabolite (MAO + COMT) HVA/DA (overall turnover) Terminal DA metabolite (MAO + COMT). HVA/DA ratio in tissue distinguishes synthesis-coupled release from enzymatic degradation — elevated when both MAO and COMT pathways are active.
3-Methoxytyramine (3-MT) Extracellular metabolite (COMT) 3-MT/DA Formed extracellularly by COMT only after DA is released. 3-MT/DA is a direct index of dopamine release — independent of MAO. Distinguishes increased release from increased synthesis.
Norepinephrine (NE) Neurotransmitter MHPG/NE MHPG/NE ratio reflects noradrenergic turnover — elevated in stress and anxiety, blunted in noradrenergic-deficient depression. CSF MHPG is a pharmacodynamic biomarker for NE reuptake inhibitors.
Normetanephrine (NMN) Extracellular metabolite (COMT) NMN/NE COMT-derived NE metabolite. NMN/NE paired with MHPG/NE distinguishes COMT vs. MAO contributions to NE clearance — relevant for COMT inhibitor monitoring.
Epinephrine (E) Hormone/neurotransmitter Metanephrine/E Adrenal medullary hormone. Metanephrine/E ratio with NE metabolites distinguishes adrenal vs. extra-adrenal catecholamine sources.
Metanephrine (MN) Metabolite (COMT) MN/E COMT-derived E metabolite. Research-grade quantitative sensitivity for the metanephrine/E ratio in plasma and tissue.

Serotonin & Tryptophan Pathway

Analyte Role Key Ratio / Index Biological Significance
Serotonin (5-HT) Neurotransmitter 5-HIAA/5-HT (serotonin turnover) 5-HIAA/5-HT ratio reflects serotonin turnover — elevated by SSRI treatment (increased synaptic 5-HT → more 5-HIAA), decreased in serotonin-deficient states. Core readout for serotonergic pharmacology.
5-Hydroxyindoleacetic acid (5-HIAA) Terminal metabolite (MAO + ALDH) 5-HIAA/5-HT Primary serotonin metabolite (MAO + ALDH). CSF 5-HIAA is reduced in depression and suicidality. 5-HIAA/5-HT ratio in brain tissue is the standard serotonin turnover index.
Tryptophan (Trp) Precursor amino acid 5-HT/Trp, Kyn/Trp Precursor for both serotonin and kynurenine pathways. 5-HT/Trp vs. Kyn/Trp reveals metabolic partitioning — shifted toward kynurenine under inflammation (IDO/TDO), reducing serotonin synthesis.
Kynurenine (Kyn) Alternative pathway metabolite Kyn/Trp (IDO/TDO activity) Kyn/Trp ratio surrogates IDO/TDO activity — elevated in neuroinflammation, depression, and immune activation. Neurotoxic vs. neuroprotective downstream partitioning tracked by quinolinic/kynurenic acid ratio.
Melatonin Pineal hormone Melatonin/5-HT Serotonin-derived circadian hormone. Melatonin/5-HT ratio reflects AANAT activity — the rate-limiting, clock-regulated enzyme for melatonin synthesis.

GABA, Glutamate & Amino Acid Neurotransmitters

Analyte Role Key Ratio / Index Biological Significance
Glutamate (Glu) Primary excitatory neurotransmitter Glu/Gln (glutamine cycle) Glu/Gln ratio reflects the neuron-astrocyte glutamate-glutamine cycle — elevated in epilepsy and excitotoxicity. Core readout for glutamatergic signaling and astrocytic glutamate recycling.
Glutamine (Gln) Precursor / glial metabolite Gln/Glu Astrocytic product of synaptically-released Glu uptake. Decreased Gln/Glu indicates impaired astrocytic glutamine synthetase — hepatic encephalopathy, neurodegeneration.
GABA Primary inhibitory neurotransmitter GABA/Glu (excitation/inhibition) Synthesized from Glu by GAD. GABA/Glu ratio reflects excitation/inhibition balance — decreased in epilepsy and anxiety; modulated by anticonvulsants and anxiolytics.
Aspartate (Asp) Co-agonist / excitatory Asp/Glu NMDA co-agonist with Glu. Asp/Glu ratio adds resolution on NMDA receptor activation state — stroke, schizophrenia, NMDA antagonist pharmacology.
Glycine Co-agonist (inhibitory + excitatory) Gly/Glu Dual-function: inhibitory co-agonist at glycine receptors AND obligatory NMDA co-agonist. Gly/Glu ratio reflects NMDA receptor glycine-site occupancy — rate-limiting for NMDA activation in most brain regions.

Acetylcholine & Histamine Pathways

Analyte Role Key Ratio / Index Biological Significance
Acetylcholine (ACh) Neurotransmitter ACh/Ch (cholinergic index) Primary cholinergic NT for cognition, memory, and autonomic function. ACh/Ch ratio reflects ChAT vs. AChE balance — requires microwave fixation for reliable quantification (ACh hydrolyzed within seconds post-mortem).
Choline (Ch) Precursor / metabolite Ch/ACh Precursor and degradation product of ACh. Elevated Ch/ACh with low ACh indicates increased AChE activity — Alzheimer's cholinergic deficit, AChE inhibitor pharmacodynamics.
Histamine Neurotransmitter / immune mediator N-Methylhistamine/Histamine Central (wakefulness, cognition) and peripheral (mast cell) roles. N-methylhistamine/histamine ratio reflects HNMT activity — primary CNS histamine clearance.
N-Methylhistamine Metabolite (HNMT) N-Methylhistamine/Histamine HNMT-derived metabolite. Paired with histamine, distinguishes increased synthesis from impaired HNMT-mediated clearance in allergy and mast cell activation.

Analytical Platform & Method for Neurotransmitter Quantification

LC-MS/MS Platform

SCIEX QTRAP 6500+ with scheduled MRM acquisition. HILIC chromatography for polar neurotransmitters and metabolites (dopamine, serotonin, GABA, glutamate, ACh, histamine, and all metabolites). Stable isotope internal standards (d4-DA, d6-NE, d6-5-HT, d5-5-HIAA, 13C5-Glu, 13C5-Gln, d6-GABA, d9-ACh, etc.) spiked at homogenization. Derivatization (dansyl chloride or benzoyl chloride) for enhanced sensitivity on low-abundance analytes (ACh, histamine).

Complementary: HPLC-ECD for electrochemical detection of catecholamines and indoleamines in microdialysate samples where ultra-low volume (below 5 uL) precludes LC-MS/MS injection. Provides cross-validation for key analytes.

Method Performance

Parameter Specification
LOD 0.01-0.5 ng/mL (sub-pg to low pg on-column); DA: 0.05 ng/mL, 5-HT: 0.1 ng/mL, ACh: 0.5 ng/mL
LLOQ 0.1-2.0 ng/mL (matrix-dependent)
Linear Range 3-4 orders of magnitude; R2 above or equal to 0.99 per analyte
Quantification Absolute — stable isotope dilution (SID) with 6-8 point calibration curves, 1/x2 weighted regression
Precision (CV) Intra-batch: below 5% (high-abundance), below 10% (trace). Inter-batch: below 15%
Spike Recovery 85-115% at low/mid/high QC levels per matrix

Neurotransmitter Analysis Workflow

1

Sample Collection & Stabilization

Brain tissue: microwave fixation preferred (instantly inactivates enzymes — essential for ACh); snap-freezing in liquid N2 acceptable for monoamines and amino acid NTs. CSF: pre-chilled tubes with ascorbic acid + EDTA, freeze within 30 min. Plasma: EDTA with sodium metabisulfite (1 mg/mL), centrifuge within 15 min at 4 degree C. Microdialysate: collect into perchloric or ascorbic acid. Dry ice shipping.

2

Sample Preparation & Derivatization

Tissue homogenization in ice-cold perchloric acid or acetonitrile:water with stable isotope IS cocktail spiked at homogenization. Protein precipitation for biofluids. Dansyl chloride or benzoyl chloride derivatization for ACh, histamine, and trace amines. SPE cleanup for complex matrices.

3

LC-MS/MS MRM Acquisition

Scheduled MRM on SCIEX QTRAP 6500+ with HILIC column, 2-3 transitions per analyte. Sequence: blank, 6-8 calibrators, matrix-matched QC, randomized study samples with QC every 8-10 injections. Matched stable isotope IS for key analytes.

4

Quantification & QC Review

Stable isotope dilution with 1/x2 weighted calibration. Turnover ratios pre-calculated per sample. QC: pooled QC RSD below 15%, IS CV below 10%, blank carryover below 1% LLOQ, calibrator accuracy within plus or minus 15%.

5

Report Delivery

Concentration table (ng/mL or ng/g) with pre-calculated turnover ratios. MRM chromatograms with IS overlay. QC report. Methods documentation. Optional: group comparisons (FDR, PCA, PLS-DA), pathway diagrams, publication-ready figures.

Neurotransmitter Analysis Workflow — Five-Step Pipeline from Sample Collection to Quantitative LC-MS/MS Data

Sample Requirements for Neurotransmitter Analysis

Sample Type Minimum Amount Critical Handling Requirements Storage & Shipping
Brain Tissue (microwave-fixed) 10-20 mg per region Microwave fixation (5-8 kW, 0.8-1.2 s) immediately after sacrifice — essential for ACh quantification. Dissect regions on ice after fixation. Record fixation parameters and warm ischemia time. -80 degree C; dry ice
Brain Tissue (frozen) 20-30 mg per region Snap-freeze in liquid N2 within 30 s of dissection. Suitable for catecholamines, indoleamines, and amino acid NTs. ACh not reliably quantifiable without microwave fixation. Record warm ischemia time. -80 degree C; dry ice
CSF 20-50 uL (rodent); 100-200 uL (large animal/human) Collect into pre-chilled polypropylene tubes with ascorbic acid (0.1% w/v) + EDTA (0.01% w/v) as antioxidant/preservative. Centrifuge (1,000 x g, 5 min, 4 degree C), aliquot, freeze within 30 min. Discard if blood-contaminated. -80 degree C; dry ice
Plasma 50-100 uL (rodent); 200-500 uL (large animal/human) EDTA or lithium heparin. Add sodium metabisulfite (1 mg/mL final). Centrifuge within 15 min of collection at 1,500 x g, 10 min, 4 degree C. Aliquot immediately. Record time from collection to freezing. -80 degree C; dry ice
Microdialysate 10-30 uL per timepoint Collect directly into perchloric acid (0.1 M final) or ascorbic acid (0.1% w/v) to stabilize. Note perfusion fluid composition, flow rate, probe type, and recovery calibration details. -80 degree C; dry ice
Urine 0.5-1 mL 24 h collection preferred with HCl (6 M, 10 mL per 24 h collection) as preservative. Record total volume for concentration normalization. Creatinine measured in parallel for output normalization. -80 degree C; dry ice

Applications of Neurotransmitter Analysis

Neuroscience & Behavior

Quantify neurotransmitter dynamics in brain regions during learning, memory, stress, and addiction. Turnover ratios distinguish synthesis from release effects. Pair with microdialysis for real-time neurochemical monitoring.

Psychiatric Drug Development

Pharmacodynamic biomarkers for antidepressants (5-HT/5-HIAA), antipsychotics (HVA/DA), and anxiolytics (GABA/Glu). Target engagement confirmation via neurotransmitter and metabolite changes in relevant brain regions.

Neurodegenerative Disease

Dopaminergic deficits in Parkinson's (DA, HVA/DA), cholinergic loss in Alzheimer's (ACh/Ch), glutamatergic excitotoxicity in ALS and Huntington's (Glu/Gln). Preclinical model characterization.

Gut-Brain Axis

Quantify serotonin (5-HT) and tryptophan/kynurenine pathway metabolites in intestinal tissue, plasma, and brain. Gut microbial regulation of host neurotransmitter pools. Fecal metabolomics integration.

Stroke & Ischemia Research

Excitotoxic glutamate release, GABAergic compensatory responses, and catecholamine surges during ischemia/reperfusion. Microdialysate time-course neurotransmitter profiling in stroke models.

Neuroinflammation

Kyn/Trp ratio as IDO/TDO activity surrogate. Quinolinic acid (NMDA agonist) vs. kynurenic acid (NMDA antagonist) balance. Neurotransmitter changes secondary to cytokine-driven metabolic reprogramming.

Monoamine Transporter Pharmacology

DAT/NET/SERT inhibitor characterization via extracellular metabolite accumulation. 3-MT/DA for DAT inhibition, MHPG/NE for NET, 5-HIAA/5-HT for SERT. Distinguish uptake blockade from release stimulation.

Metabolomics Integration

Pair neurotransmitter data with broader multi-omics integration — transcriptomics (receptor/transporter expression), proteomics (enzyme levels), and metabolomics (precursor amino acid pools) for systems-level neurochemical modeling.

Deliverables — What You Receive

  • Quantitative Concentration Table — Absolute concentrations (ng/mL or ng/g tissue) for each analyte per sample. Excel and CSV. Turnover ratios pre-calculated. LOD/LLOQ flags and IS recovery per sample.
  • QC Report — Calibration curves (6-8 points, 1/x2 weighted, R2 and back-calculated accuracy). Pooled QC RSD. IS recovery per sample. Blank carryover. Spike recovery at 3 levels per matrix.
  • MRM Chromatograms — Extracted ion chromatograms for each analyte with co-eluting stable isotope IS overlay. MS/MS confirmation spectra for isomer identification.
  • Methods Documentation — Complete LC-MS/MS parameters, derivatization protocol, extraction method, data processing settings. Formatted for manuscript methods section.
  • Optional Statistical Analysis — Group comparisons (t-test/ANOVA, FDR, volcano/box plots), PCA/PLS-DA, pathway diagrams, publication-ready figures (300 DPI TIFF + vector PDF/AI).

Data Visualizations

Neurotransmitter MRM Chromatogram — HILIC Separation of Dopamine, Serotonin, and Metabolites with IS Overlay

HILIC MRM chromatogram: dopamine, serotonin, norepinephrine, and key metabolites (HVA, DOPAC, 5-HIAA, MHPG) with co-eluting stable isotope internal standards, demonstrating baseline resolution and retention time stability.

Neurotransmitter Calibration Curves — 6-Point Stable Isotope Dilution Calibration for Dopamine and Serotonin

Stable isotope dilution calibration curves for dopamine and serotonin (6 points, 1/x2 weighted regression, R2 above 0.998), with LOD and LLOQ indicated per analyte.

Neurotransmitter Turnover Ratios — Box Plots of HVA/DA and 5-HIAA/5-HT Across Treatment Groups

Turnover ratio box plots: HVA/DA and 5-HIAA/5-HT across experimental groups with FDR-corrected significance, demonstrating the superior biological resolution of metabolite-to-parent ratios over static concentrations.

Neurotransmitter Pathway Map — Catecholamine and Serotonin Biosynthesis and Metabolism with Fold-Change Node Coloring

Integrated neurotransmitter pathway map: catecholamine and serotonin biosynthesis and metabolism with detected metabolites colored by fold-change, showing synthesis, release, reuptake, and degradation pathway coverage.

Case Study — Simultaneous Quantification of 15 Neurotransmitters in a Single Rodent Brain Sample: From Tissue to Microdialysate

Validated methods for determination of neurotransmitters and metabolites in rodent brain tissue and extracellular fluid by reversed phase UHPLC-MS/MS

Van Schoors, J., Viaene, J., Van Wanseele, Y., et al. | Journal of Chromatography A, 2016, 1443, 73-83 | IF: 3.8

DOI: 10.1016/j.jchromb.2016.06.011


What They Needed

Quantifying all major neurotransmitter classes — monoamines, their metabolites, amino acid neurotransmitters, and acetylcholine — from a single brain sample is analytically demanding. The core problems: glutamate is present at uM while serotonin and ACh are at low nM (10,000-fold difference), ACh is hydrolyzed within seconds of death, and brain tissue phospholipids cause severe ion suppression in ESI-MS. The researchers needed one validated method that could handle both brain tissue homogenates AND microdialysate — matrices with vastly different concentration ranges and interference profiles.

What They Got

Van Schoors et al. developed a reversed-phase UHPLC-MS/MS method with dansyl chloride derivatization that simultaneously quantified 15 neurotransmitters and metabolites across monoamine, amino acid, and acetylcholine pathways from a single injection:

Parameter Brain Tissue Microdialysate
LOD 0.01-0.5 ng/mL 0.01-0.3 ng/mL
Precision (intra-batch) Below 8% CV Below 10% CV
Spike recovery 88-108% 85-112%
Linear range 4 orders of magnitude 3 orders of magnitude

The dansyl chloride derivatization step was the key innovation — enhancing sensitivity for low-abundance monoamines 10-50x while improving chromatographic retention. Applied to rat brain, the method revealed clear region-specific neurotransmitter profiles: striatum dominated by dopamine (12.5 ng/mg, DOPAC/DA 0.32), hippocampus by acetylcholine (2.8 ng/mg), and prefrontal cortex by serotonin (0.9 ng/mg, 5-HIAA/5-HT 1.4).

Why This Matters for Your Research

The region-specific neurotransmitter profiles reported here — striatal DA (12.5 ng/mg), hippocampal ACh (2.8 ng/mg), cortical 5-HT (0.9 ng/mg) — are not just numbers. They demonstrate that a single validated LC-MS/MS method can resolve neuroanatomical differences in neurotransmitter systems simultaneously. If you are comparing wild-type vs. knockout brain regions, tracking drug-induced neurotransmitter changes over a time course, or profiling microdialysate fractions before and after a behavioral intervention, this is your analytical framework. You do not need separate assays for monoamines, amino acids, and acetylcholine — one injection, one report, all ratios pre-calculated.

How Our Service Delivers the Same Rigor

This study mirrors our neurotransmitter panel: (1) a single extraction and injection covering monoamines, amino acid NTs, and acetylcholine — no need for separate assays; (2) stable isotope internal standards with documented precision and recovery; (3) matrix-specific validation giving you confidence in data across brain tissue, CSF, plasma, and microdialysate. When you submit your samples, every neurotransmitter is resolved, every metabolite tracked, and every turnover ratio pre-calculated — the same analytical framework, applied to your experiment.

Reference

  1. Van Schoors, J., Viaene, J., Van Wanseele, Y., et al. Validated methods for determination of neurotransmitters and metabolites in rodent brain tissue and extracellular fluid by reversed phase UHPLC-MS/MS. Journal of Chromatography A 1443, 73-83 (2016).

Frequently Asked Questions

Why measure neurotransmitter metabolites and ratios instead of just the neurotransmitters themselves?

A static neurotransmitter concentration tells you the pool size at one moment — not whether the neuron is firing more, reuptake is blocked, or enzymatic degradation is changing. Metabolite-to-parent ratios reveal flux through the system: HVA/DA indicates overall dopamine turnover (synthesis + release + degradation), 3-MT/DA specifically tracks dopamine release (3-MT is only formed extracellularly after exocytotic DA release), and 5-HIAA/5-HT reflects serotonin metabolism. If you only measure DA and 5-HT without their metabolites, you miss whether a concentration change comes from altered synthesis, altered release, or altered clearance — three completely different biological mechanisms that look identical in static concentration data.

How many neurotransmitters can you quantify in a single analysis?

30+ analytes across 5 pathways in a single HILIC LC-MS/MS injection: catecholamines (DA, NE, E, DOPAC, HVA, 3-MT, MHPG, NMN, MN), serotonin pathway (5-HT, 5-HIAA, Trp, Kyn, melatonin), GABA/glutamate (Glu, Gln, GABA, Asp, Gly), acetylcholine pathway (ACh, Ch), and histamine pathway (histamine, N-methylhistamine). Each analyte has its own stable isotope internal standard. The panel is modular — if you only need catecholamines, we run a focused sub-panel.

What sample types can you analyze and how should they be collected?

Brain tissue: microwave fixation strongly recommended for ACh (hydrolyzed within seconds post-mortem). Snap-freezing in liquid N2 acceptable for monoamines and amino acid NTs. CSF: collect into pre-chilled tubes with antioxidant (ascorbic acid + EDTA), freeze within 30 min. Plasma: EDTA with sodium metabisulfite stabilizer, centrifuge within 15 min. Microdialysate: collect into perchloric acid or ascorbic acid. Urine: 24 h collection with HCl preservative. See Sample Requirements table above for detailed volumes and protocols.

How does LC-MS/MS compare to ELISA or HPLC-ECD for neurotransmitter analysis?

ELISA is single-analyte, semi-quantitative, and prone to cross-reactivity — you cannot measure DA alongside its metabolites DOPAC and HVA in one well. HPLC-ECD offers multi-analyte capability with good sensitivity but cannot distinguish co-eluting compounds — a pure electrochemical signal alone cannot confirm the identity of the peak. LC-MS/MS combines chromatographic separation with mass-selective detection plus structural confirmation via MS/MS fragmentation — you know not just "there is a peak at 6.2 min" but "this is dopamine confirmed by its MRM transition and fragment spectrum, quantified against its d4-labeled internal standard." For publication-quality neurotransmitter data, LC-MS/MS with stable isotope dilution is the gold standard.

What are the detection limits for key neurotransmitters?

LOD ranges from 0.01-0.5 ng/mL (sub-pg to low pg on-column) depending on the analyte: DA ~0.05 ng/mL, 5-HT ~0.1 ng/mL, NE ~0.05 ng/mL, GABA ~0.5 ng/mL, Glu ~1.0 ng/mL, ACh ~0.5 ng/mL (with derivatization). LLOQ: 0.1-2.0 ng/mL. These detection limits enable quantification from microdialysate (10-30 uL), discrete brain nuclei microdissections (1-5 mg tissue), and individual mouse CSF samples (5-10 uL). Each analyte's LOD and LLOQ are documented in the QC report for your specific matrix.

Why is microwave fixation important for brain tissue neurotransmitter analysis?

Post-mortem neurotransmitter metabolism begins within seconds of death. Acetylcholine is the most labile — brain ACh concentrations drop by over 80% within 30 seconds of decapitation if not microwave-fixed, making frozen tissue ACh data unreliable. Catecholamines and indoleamines are more stable but still show 10-30% post-mortem changes within 1-2 minutes. Microwave fixation (5-8 kW, 0.8-1.2 s) instantly denatures all enzymes (AChE, MAO, COMT, ChAT) by rapid thermal denaturation, freezing the in vivo neurochemical state. If microwave fixation is not available, snap-freezing in liquid N2 is acceptable for monoamines and amino acid NTs (with documented warm ischemia time), but ACh data will be unreliable.

Selected Publications in Neurotransmitter Analysis

Validated methods for determination of neurotransmitters and metabolites in rodent brain tissue and extracellular fluid by reversed phase UHPLC-MS/MS

Van Schoors, J., Viaene, J., Van Wanseele, Y., et al.

Journal: Journal of Chromatography A

Year: 2016

DOI: https://doi.org/10.1016/j.jchromb.2016.06.011

Quantitative analysis of neurochemical panel in rat brain and plasma by liquid chromatography-tandem mass spectrometry

Kovac, A., Somikova, Z., Zilka, N., & Novak, M.

Journal: Talanta

Year: 2014

DOI: https://doi.org/10.1016/j.talanta.2013.10.047

LC-ESI-MS-MS method for monitoring dopamine, serotonin and their metabolites in brain tissue

Wojnicz, A., Avendano-Ortiz, J., de Pascual-Teresa, M.A., et al.

Journal: Chromatographia

Year: 2016

DOI: https://doi.org/10.1007/s10337-016-3103-9

Simultaneous determination of 16 neurotransmitters and metabolites in human plasma using UPLC-MS/MS with dansyl chloride derivatization

Zheng, J., Mandal, R., & Wishart, D.S.

Journal: Analytica Chimica Acta

Year: 2018

DOI: https://doi.org/10.1016/j.aca.2018.07.060

Development and validation of a UHPLC-MS/MS method for the simultaneous determination of 11 neurotransmitters in rat brain

He, B., Bi, K., Jia, Y., et al.

Journal: Journal of Pharmaceutical and Biomedical Analysis

Year: 2016

DOI: https://doi.org/10.1016/j.jpba.2016.03.038

Ionic liquid based ultrasound assisted dispersive liquid-liquid micro-extraction for simultaneous determination of 15 neurotransmitters in rat brain, plasma and cell samples

Zhu, K., et al.

Journal: Journal of Chromatography A

Year: 2020

DOI: https://doi.org/10.1016/j.chroma.2020.461096

Central biogenic amine deficiency with concomitant exploratory behavioral deficits in Dnajc12 knock-out mice

Deng, I.B., et al.

Journal: NPJ Parkinson's Disease

Year: 2025

DOI: https://doi.org/10.1038/s41531-025-00991-4

Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity

Liebmann, M., Korn, L., Janoschka, C., et al.

Journal: Brain

Year: 2021

DOI: https://doi.org/10.1093/brain/awab307

Neurotransmitters analysis by LC-MS/MS: recent developments and applications in neuroscience research

Helmschrodt, C., Becker, S., Perl, T., et al.

Journal: Bioanalysis

Year: 2020

DOI: https://doi.org/10.4155/bio-2020-0125

UDP-Glucose/P2Y14 Receptor Signaling Exacerbates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats

Kanamaru, H., Zhu, S., Dong, S., et al.

Journal: Stroke

Year: 2024

DOI: https://doi.org/10.1161/STROKEAHA.123.044422

For Research Use Only. Not for use in diagnostic procedures.
inquiry

Get Your Custom Quote

Connect with Creative Proteomics Contact UsContact Us
return-top